LSI Stock Overview
An investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CK Life Sciences Int'l., (Holdings) Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.048 |
| 52 Week High | HK$0.07 |
| 52 Week Low | HK$0.032 |
| Beta | 0.11 |
| 11 Month Change | -4.00% |
| 3 Month Change | 39.13% |
| 1 Year Change | -31.91% |
| 33 Year Change | -38.85% |
| 5 Year Change | -43.86% |
| Change since IPO | -23.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| LSI | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -2.0% | -0.7% | 0.2% |
| 1Y | -31.9% | -17.2% | 8.5% |
Return vs Industry: LSI underperformed the German Biotechs industry which returned -17.2% over the past year.
Return vs Market: LSI underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| LSI volatility | |
|---|---|
| LSI Average Weekly Movement | 11.4% |
| Biotechs Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: LSI's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: LSI's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 1,968 | Lance Richard Lee Yuen | www.ck-lifesciences.com |
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products.
CK Life Sciences Int'l., (Holdings) Inc. Fundamentals Summary
| LSI fundamental statistics | |
|---|---|
| Market cap | €517.76m |
| Earnings (TTM) | -€2.28m |
| Revenue (TTM) | €658.63m |
0.8x
P/S Ratio-226.6x
P/E RatioIs LSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LSI income statement (TTM) | |
|---|---|
| Revenue | HK$5.38b |
| Cost of Revenue | HK$3.74b |
| Gross Profit | HK$1.64b |
| Other Expenses | HK$1.66b |
| Earnings | -HK$18.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 30.43% |
| Net Profit Margin | -0.35% |
| Debt/Equity Ratio | 136.3% |
How did LSI perform over the long term?
See historical performance and comparison